Sara Emad El-Agamy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sara Emad El-Agamy has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Francesca Mattedi
UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK
1 shared publication - Keiko Kono
Okinawa Institute of Science and Technology Graduate University
1 shared publication - Laurent Guillaud
Molecular Neuroscience Unit, Okinawa Institute of Science and Technology Graduate University, Kunigami-gun, Okinawa 904-0412, Japan
1 shared publication - Marco Terenzio
Molecular Neuroscience Unit, Okinawa Institute of Science and Technology Graduate University, Kunigami-gun, Okinawa 904-0412, Japan
1 shared publication - Pietro Fratta
UCL Queen Square Motor Neuron Disease Centre and Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, University College London, London, UK
1 shared publication - Yibo Wu
Chemical Biology Mass Spectrometry Platform, Faculty of Sciences, University of Geneva, Geneva, Switzerland
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by Annual Reviews in Annual Review of Genomics and Human Genetics
- Vol. 27 (1) , 277-303
Cryptic Splicing in ALS: From Driving Disease Progression to Unlocking Novel Therapeutics
TDP-43 is an RNA-binding protein that regulates multiple aspects of RNA processing, and its mislocalization from the nucleus to the cytoplasm is a defining feature of amyotrophic lateral sclerosis (ALS). While both loss- and gain-of-function mechanisms contribute to disease, the discovery of cryptic splicing has shed light on the downstream consequences of TDP-43 nuclear clearance for neuronal health. Here, we highlight how loss of nuclear TDP-43 can drive a cascade of events that lead to the impairment of cellular proteostasis and result in a positive feedback loop that perpetuates neuronal dysfunction. This sustains the appearance of cryptic splicing events in genes that are involved in key pathways for the maintenance of axonal homeostasis and synaptic transmission. In contrast to their detrimental effects on neuronal health, cryptic splicing mechanisms may be harnessed to develop novel therapeutic strategies, unprecedentedly expanding the availability of therapeutic avenues for TDP-43 proteinopathies.
- 21 April 2026
- Published by Annual Reviews in Annual Review of Genomics and Human Genetics
- Vol. 27 (1) , 277-303
Open AccessCryptic Splicing in ALS: From Driving Disease Progression to Unlocking Novel Therapeutics
TDP-43 is an RNA-binding protein that regulates multiple aspects of RNA processing, and its mislocalization from the nucleus to the cytoplasm is a defining feature of amyotrophic lateral sclerosis (ALS). While both loss- and gain-of-function mechanisms contribute to disease, the discovery of cryptic splicing has shed light on the downstream consequences of TDP-43 nuclear clearance for neuronal health. Here, we highlight how loss of nuclear TDP-43 can drive a cascade of events that lead to the impairment of cellular proteostasis and result in a positive feedback loop that perpetuates neuronal dysfunction. This sustains the appearance of cryptic splicing events in genes that are involved in key pathways for the maintenance of axonal homeostasis and synaptic transmission. In contrast to their detrimental effects on neuronal health, cryptic splicing mechanisms may be harnessed to develop novel therapeutic strategies, unprecedentedly expanding the availability of therapeutic avenues for TDP-43 proteinopathies.
- Open Access
- 20 September 2023
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 22 (11) , 100653
FMRP Long-Range Transport and Degradation Are Mediated by Dynlrb1 in Sensory Neurons
- 20 September 2023
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 22 (11) , 100653
Open AccessFMRP Long-Range Transport and Degradation Are Mediated by Dynlrb1 in Sensory Neurons